Key Takeaways GEHC Q3 revenues are estimated at $5.07B, up 4.2$1.05.GEHC's Imaging and Pharmaceutical Diagnostics likely offset weakness in Patient Care Solutions.Tariff costs are expected to pressure GEHC's margins, driving a high-single-digit EBITDA decline.GE HealthCare Technologies Inc. (GEHC) is scheduled to report third-quarter 2025 results on Oct. 29, before market open.In the last reported quarter, the company’s adjusted earnings per share (EPS) of $1.06 surpassed the Z ...